Correlation Between Organogenesis Holdings and China Pharma
Can any of the company-specific risk be diversified away by investing in both Organogenesis Holdings and China Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Organogenesis Holdings and China Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Organogenesis Holdings and China Pharma Holdings, you can compare the effects of market volatilities on Organogenesis Holdings and China Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Organogenesis Holdings with a short position of China Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Organogenesis Holdings and China Pharma.
Diversification Opportunities for Organogenesis Holdings and China Pharma
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Organogenesis and China is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Organogenesis Holdings and China Pharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Pharma Holdings and Organogenesis Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Organogenesis Holdings are associated (or correlated) with China Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Pharma Holdings has no effect on the direction of Organogenesis Holdings i.e., Organogenesis Holdings and China Pharma go up and down completely randomly.
Pair Corralation between Organogenesis Holdings and China Pharma
Given the investment horizon of 90 days Organogenesis Holdings is expected to generate 1.56 times more return on investment than China Pharma. However, Organogenesis Holdings is 1.56 times more volatile than China Pharma Holdings. It trades about 0.21 of its potential returns per unit of risk. China Pharma Holdings is currently generating about -0.23 per unit of risk. If you would invest 289.00 in Organogenesis Holdings on August 31, 2024 and sell it today you would earn a total of 98.00 from holding Organogenesis Holdings or generate 33.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Organogenesis Holdings vs. China Pharma Holdings
Performance |
| Timeline |
| Organogenesis Holdings |
| China Pharma Holdings |
Organogenesis Holdings and China Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Organogenesis Holdings and China Pharma
The main advantage of trading using opposite Organogenesis Holdings and China Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Organogenesis Holdings position performs unexpectedly, China Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Pharma will offset losses from the drop in China Pharma's long position.The idea behind Organogenesis Holdings and China Pharma Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| China Pharma vs. Universe Pharmaceuticals | China Pharma vs. Sonoma Pharmaceuticals | China Pharma vs. Akanda Corp | China Pharma vs. Halo Collective |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |